vs
BIOMERICA INC（BMRA）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
BIOMERICA INC的季度营收约是Arcadia Biosciences, Inc.的1.3倍（$1.2M vs $901.0K），BIOMERICA INC净利率更高（-109.1% vs -148.3%，领先39.2%），Arcadia Biosciences, Inc.同比增速更快（-25.8% vs -26.0%），过去两年Arcadia Biosciences, Inc.的营收复合增速更高（-4.5% vs -12.1%）
Biomerica Inc.是一家全球性医疗技术企业，研发、生产及销售诊断检测试剂盒与相关医疗产品，产品线覆盖胃肠疾病、传染病、食物不耐受检测及即时检测解决方案，服务全球多地的临床实验室、医疗机构及零售医疗客户。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
BMRA vs RKDA — 直观对比
营收规模更大
BMRA
是对方的1.3倍
$901.0K
营收增速更快
RKDA
高出0.2%
-26.0%
净利率更高
BMRA
高出39.2%
-148.3%
两年增速更快
RKDA
近两年复合增速
-12.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2M | $901.0K |
| 净利润 | $-1.3M | $-1.3M |
| 毛利率 | 4.2% | 21.4% |
| 营业利润率 | -113.5% | -152.8% |
| 净利率 | -109.1% | -148.3% |
| 营收同比 | -26.0% | -25.8% |
| 净利润同比 | -38.9% | 67.1% |
| 每股收益（稀释后） | $-0.45 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BMRARKDA
| Q4 25 | $1.2M | $901.0K | ||
| Q3 25 | $1.4M | $1.3M | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | $1.1M | $1.2M | ||
| Q4 24 | $1.6M | $1.2M | ||
| Q3 24 | $1.8M | $1.5M | ||
| Q2 24 | $1.1M | $1.3M | ||
| Q1 24 | $1.0M | $987.0K |
净利润BMRARKDA
| Q4 25 | $-1.3M | $-1.3M | ||
| Q3 25 | $2.0K | $856.0K | ||
| Q2 25 | — | $-4.5M | ||
| Q1 25 | $-1.2M | $2.6M | ||
| Q4 24 | $-950.0K | $-4.1M | ||
| Q3 24 | $-1.3M | $-1.6M | ||
| Q2 24 | $-1.4M | $1.1M | ||
| Q1 24 | $-1.9M | $-2.4M |
毛利率BMRARKDA
| Q4 25 | 4.2% | 21.4% | ||
| Q3 25 | 30.7% | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | 1.7% | 43.2% | ||
| Q4 24 | 26.7% | 31.9% | ||
| Q3 24 | 16.0% | 32.9% | ||
| Q2 24 | 2.1% | 51.5% | ||
| Q1 24 | -14.7% | 52.3% |
营业利润率BMRARKDA
| Q4 25 | -113.5% | -152.8% | ||
| Q3 25 | -81.0% | -88.5% | ||
| Q2 25 | — | -34.4% | ||
| Q1 25 | -108.1% | 44.2% | ||
| Q4 24 | -60.7% | -187.7% | ||
| Q3 24 | -75.7% | -114.5% | ||
| Q2 24 | -136.6% | — | ||
| Q1 24 | -196.7% | -160.9% |
净利率BMRARKDA
| Q4 25 | -109.1% | -148.3% | ||
| Q3 25 | 0.1% | 65.7% | ||
| Q2 25 | — | -306.4% | ||
| Q1 25 | -103.9% | 216.6% | ||
| Q4 24 | -58.1% | -334.5% | ||
| Q3 24 | -72.8% | -104.9% | ||
| Q2 24 | -127.1% | 81.2% | ||
| Q1 24 | -188.6% | -245.5% |
每股收益（稀释后）BMRARKDA
| Q4 25 | $-0.45 | $-0.97 | ||
| Q3 25 | $0.00 | $0.62 | ||
| Q2 25 | — | $-3.26 | ||
| Q1 25 | $-0.48 | $1.90 | ||
| Q4 24 | $-0.06 | $-2.99 | ||
| Q3 24 | $-0.63 | $-1.18 | ||
| Q2 24 | $-2.57 | $0.78 | ||
| Q1 24 | $-0.11 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.4M | $4.1M |
| 总资产 | $6.0M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BMRARKDA
| Q4 25 | $2.5M | $4.6M | ||
| Q3 25 | $3.1M | $5.9M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | $3.1M | $3.2M | ||
| Q4 24 | $2.4M | $4.2M | ||
| Q3 24 | $2.8M | $6.6M | ||
| Q2 24 | $4.2M | $8.1M | ||
| Q1 24 | $5.3M | $8.5M |
股东权益BMRARKDA
| Q4 25 | $4.4M | $4.1M | ||
| Q3 25 | $5.2M | $5.4M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | $5.5M | $8.9M | ||
| Q4 24 | $5.1M | $6.2M | ||
| Q3 24 | $5.3M | $10.3M | ||
| Q2 24 | $6.6M | $11.7M | ||
| Q1 24 | $7.8M | $10.6M |
总资产BMRARKDA
| Q4 25 | $6.0M | $6.5M | ||
| Q3 25 | $6.9M | $8.6M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | $7.4M | $13.0M | ||
| Q4 24 | $7.3M | $13.5M | ||
| Q3 24 | $7.9M | $15.2M | ||
| Q2 24 | $9.3M | $17.4M | ||
| Q1 24 | $10.3M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-991.0K | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BMRARKDA
| Q4 25 | $-991.0K | $-861.0K | ||
| Q3 25 | $-268.0K | $-257.0K | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | $-1.0M | $-1.6M | ||
| Q4 24 | $-791.0K | $-2.2M | ||
| Q3 24 | $-1.3M | $-1.8M | ||
| Q2 24 | $-1.0M | $-2.5M | ||
| Q1 24 | $-1.8M | $-3.2M |
自由现金流BMRARKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.1M | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率BMRARKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -95.5% | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度BMRARKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 2.1% | 0.2% | ||
| Q1 24 | 0.0% | 1.3% |
现金转化率BMRARKDA
| Q4 25 | — | — | ||
| Q3 25 | -134.00× | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
